ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.

Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement

News | Optical Coherence Tomography (OCT)

Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases

August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...

August 29, 2023

The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study set to enrol the first patient this summer.

News | Implantable Cardioverter Defibrillator (ICD)

Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

August 28, 2023

HEART-FID trial presented in a Hot Line session Saturday at ESC Congress 2023

News | Heart Failure

Trial of Ferric Carboxymaltose in Heart Failure Does Not Meet Primary Endpoint

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure hospitalizat ...

August 28, 2023

BUDAPEST CRT Upgrade trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Implantable Cardioverter Defibrillator (ICD)

Upgrade to Cardiac Resynchronization Therapy Benefits Heart Failure Patients with Pacing

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

August 28, 2023

STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Antiplatelet and Anticoagulation Therapies

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

August 28, 2023

Integrating and analyzing data over time and across various data sources, CardioVisio for Atrial Fibrillation helps visualize the history of the patient’s heart and provides guideline-directed insights to healthcare providers

News | Atrial Fibrillation

GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

August 24, 2023 — GE HealthCare announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool ...

August 24, 2023

Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help improve clinical confidence and increase efficiency.

News | Cardiovascular Ultrasound

Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

August 24, 2023

Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardial infarction, stroke or death compared with those who consistently take the drug, according to research presented at ESC Congress 2023

News | ESC

Heart Attack Patients Should Take Aspirin to Avoid a New Heart Attack, Stroke and Death

August 22, 2023 — Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardia ...

August 22, 2023

A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrial fibrillation and stroke.

News | ESC

Keep Fit to Avoid Heart Rhythm Disorder and Stroke

August 22, 2023 — A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood ...

August 22, 2023

Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according to research presented at ESC Congress 2023

News | ESC

Heart Attack Victims Who Recognize Symptoms are Less Likely to Die in Hospital

August 22, 2023 — Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according ...

August 22, 2023

Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates on prevention and lipid lowering” at the 2023 ESC Congress

News | Cardiovascular Clinical Studies

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

August 14, 2023 — Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled ...

August 14, 2023

Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first year while depression affects one in five. That’s the finding of a study

News | Artificial Heart

Post-traumatic Stress Disorder Affects More Than One in Ten Cardiac Device Patients

July 3, 2023 — Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first ...

July 03, 2023

Women with atrial fibrillation progress more rapidly to cognitive impairment and dementia than men with the heart rhythm condition, according to research presented today at ACNAP 2023

News | Atrial Fibrillation

Women with Common Heart Rhythm Disorder Have Faster Cognitive Decline Than Men

June 30, 2023 — Women with atrial fibrillation progress more rapidly to cognitive impairment and dementia than men with ...

June 30, 2023

Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.

News | Coronavirus (COVID-19)

One Month of COVID-19 Lockdown Cost Heart Attack Patients Up to Two Years of Life

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to ...

June 19, 2023

PARAGLIDE-HF trial presented in a late breaking science session today at Heart Failure 2023

News | Heart Failure

Sacubitril/Valsartan Shows Benefit in Heart Failure with Ejection Fraction Above 40%

May 23, 2023 — Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone ...

May 23, 2023